besthealtharticle.com
Home »
ZURICH (Reuters) – Vaccines from AstraZeneca, Russia’s Gamaleya Institute and Johnson & Johnson fight the coronavirus with another virus, leaving scientists concerned the shots may lose potency if annual inoculations become necessary to fight new variants. So-called viral vector shots – also used by several Chinese COVID-19 vaccine developers – use harmless modified viruses as […]
The Massachusetts Institute of Technology announced this week that researchers had used machine learning to identify medications that may be repurposed to fight COVID-19. “Making new drugs takes forever,” Caroline Uhler, a computational biologist in MIT’s Department of Electrical Engineering and Computer Science and the Institute for Data, Systems and Society, said in a […]
The Office of the National Coordinator for Health IT this week launched its new Synthetic Health Data Challenge – offering researchers a chance to explore new avenues of medical research. WHY IT MATTERS The new challenge is part of ONC’s Synthetic Health Data Generation to Accelerate Patient-Centered Outcomes Research project. Participants are invited to develop […]
A team of researchers in Sweden has discovered that an artificial intelligence platform is capable of accurately diagnosing prostate cancer in tissue samples, offering the potential to speed up diagnostics and reduce costs for healthcare services The findings, published in The Lancet Oncology in December, suggest AI systems can be trained to detect and grade […]
The McDonnell Genome Institute at Washington University School of Medicine in St. Louis is entering a new era of genomic medicine, expanding its capacities beyond genome sequencing and adding a new and vital focus on understanding how genetics influences health and disease. Jeffrey Milbrandt, MD, PhD, recently appointed executive director of the McDonnell Genome Institute, […]
HIMSS is accepting speaker proposals for six pre-conference symposiums on Feb. 11 in Orlando. The deadline to submit a proposal is 5 p.m. EST, Oct. 19. Case studies from healthcare provider and payer organizations are a focus for these events, which deliver deep-dives into specific topic categories. Click on the links below to learn more […]
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database. The deal comes as GlaxoSmithKline amid reports that GSK is weighing the possibility of a company breakup and investors contending that synergies between consumer markets and big pharma are inherently limited and that GSK’s […]
While the use of telemedicine systems has been expanding in recent years, especially as more payers, including the government, have begun reimbursing for telehealth services in some instances, the industry is on the verge of more widespread virtual care. But what will that ultimately look like? The next generation of tools will feature enhancements ranging […]